arginyl-glycyl-aspartic acid and Lassitude

arginyl-glycyl-aspartic acid has been researched along with Lassitude in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cerullo, V; Diaconu, I; Dotti, G; Escutenaire, S; Guse, K; Haavisto, E; Hannuksela, P; Hemminki, A; Holm, SL; Joensuu, T; Kanerva, A; Kangasniemi, L; Karioja-Kallio, A; Karli, E; Kauppinen, S; Laasonen, L; Nokisalmi, P; Oksanen, M; Partanen, K; Pesonen, S; Raki, M	1

Trials

1 trial(s) available for arginyl-glycyl-aspartic acid and Lassitude

Article	Year
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors. International journal of cancer, 2012, Apr-15, Volume: 130, Issue:8 Topics: Adenoviridae; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA, Viral; Drug Resistance, Neoplasm; Fatigue; Female; Fever; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Integrins; Male; Middle Aged; Neoplasms; Oligopeptides; Oncolytic Virotherapy; Oncolytic Viruses; Real-Time Polymerase Chain Reaction; Treatment Outcome; Viral Load; Virus Replication	2012

Article

Year

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.

International journal of cancer, 2012, Apr-15, Volume: 130, Issue:8

Topics: Adenoviridae; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; DNA, Viral; Drug Resistance, Neoplasm; Fatigue; Female; Fever; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Integrins; Male; Middle Aged; Neoplasms; Oligopeptides; Oncolytic Virotherapy; Oncolytic Viruses; Real-Time Polymerase Chain Reaction; Treatment Outcome; Viral Load; Virus Replication

2012